There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

Fenugreek, jamun and cinnamon are touted as miracle cures for diabetes. Aishwarya A Kumbhakoni shares if there's any scientific evidence to support this claim.

CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them at risk for dangerous seizures or loss of consciousness due to severe low ...

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Add Yahoo as a preferred source to see more of our stories on Google. This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with ...

When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an ...

An experimental surgery may provide relief to some diabetics. April 13, 2008 — -- A new, experimental surgery could make type 2 diabetes disappear in some patients. While doctors have refrained ...

Over 170 attendees raised over $60,000 at the 19th annual Cooking for a Cure fundraiser for the Diabetes Research Institute Foundation. The annual event, held on Wednesday, April 9, at the Crescent ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...